CD34+ a Novel Predictor of Vascular Events in Sickle Cell Disease

CD34+ a Novel Predictor of Vascular Events in Sickle Cell Disease

CD34+ Hematopoietic Stem Cell Count as a Novel Predictor of Vascular Event in Sickle Cell Disease Patients

Versandkostenfrei!
Versandfertig in 6-10 Tagen
40,99 €
inkl. MwSt.
PAYBACK Punkte
20 °P sammeln!
Our aim is to evaluate circulating CD34 as a novel predictive marker of occurrence of vascular event in Children with Sickle Cell Disease in their steady state and relate levels to severity of VEs in the following 6 months.Patient and Methods: This study was an exploratory study, conducted at Pediatrics Hematology-Oncology Unit at Ain Shams University Children's Hospital, where 50 children with sickle cell disease were enrolled at their steady state (defined as 2 months free from any Vascular Event prior to the study), aged 6 months - 16 years. Flow cytometry was done for quantification of cir...